cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.450
+0.006 (1.47%)
At close: Feb 21, 2025, 4:00 PM
0.455
+0.005 (1.11%)
After-hours: Feb 21, 2025, 7:58 PM EST
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2018 |
| Revenue | 19.22 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade
|
| Revenue Growth (YoY) | -18.02% | -19.35% | -31.77% | -20.41% | 6.20% | 77.09% | Upgrade
|
| Cost of Revenue | 7.38 | 7.49 | 9.18 | 13.07 | 14.5 | 15.51 | Upgrade
|
| Gross Profit | 11.84 | 12 | 14.98 | 22.34 | 29.99 | 26.37 | Upgrade
|
| Selling, General & Admin | 12.32 | 13.27 | 18.93 | 33.29 | 43.37 | 38.83 | Upgrade
|
| Research & Development | 0.04 | 0.04 | 0.17 | 0.63 | 1.42 | 0.42 | Upgrade
|
| Other Operating Expenses | 0.65 | 0.86 | 3.34 | 3.89 | 3.79 | 3.97 | Upgrade
|
| Operating Expenses | 14.17 | 15.31 | 24.25 | 39.65 | 49.6 | 43.95 | Upgrade
|
| Operating Income | -2.34 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | - | - | -0.03 | - | Upgrade
|
| Interest & Investment Income | 0.01 | - | 0.06 | 0.02 | - | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.24 | 0.03 | - | Upgrade
|
| EBT Excluding Unusual Items | -2.35 | -3.34 | -9.2 | -17.06 | -19.62 | -17.54 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.6 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -56.67 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.7 | -0.03 | 0.55 | -0.93 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.09 | - | - | Upgrade
|
| Asset Writedown | - | - | -13.22 | -4.29 | - | - | Upgrade
|
| Other Unusual Items | -0.33 | -0.36 | 0.19 | 8.47 | -5.22 | 29.78 | Upgrade
|
| Pretax Income | -2.69 | -3.7 | -22.94 | -70.08 | -24.29 | 11.31 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.9 | -1.35 | Upgrade
|
| Earnings From Continuing Operations | -2.69 | -3.7 | -22.94 | -70.08 | -23.39 | 12.65 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -0.05 | Upgrade
|
| Net Income | -2.69 | -3.7 | -22.94 | -70.08 | -23.39 | 12.6 | Upgrade
|
| Preferred Dividends & Other Adjustments | 4 | 4 | 4 | 4 | 2.55 | 0.37 | Upgrade
|
| Net Income to Common | -6.69 | -7.7 | -26.94 | -74.09 | -25.95 | 12.24 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 94.06% | 113.25% | 52.31% | 8.76% | 21.62% | 152.54% | Upgrade
|
| EPS (Basic) | -1.42 | -1.79 | -13.32 | -55.80 | -21.26 | 12.47 | Upgrade
|
| EPS (Diluted) | -1.42 | -1.79 | -13.32 | -55.80 | -21.26 | 12.47 | Upgrade
|
| Free Cash Flow | -0.73 | -0.54 | -4.6 | -15.66 | -14.44 | -11.98 | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.13 | -2.27 | -11.79 | -11.82 | -11.94 | Upgrade
|
| Gross Margin | 61.59% | 61.57% | 62.01% | 63.09% | 67.41% | 62.96% | Upgrade
|
| Operating Margin | -12.15% | -17.02% | -38.37% | -48.90% | -44.10% | -41.98% | Upgrade
|
| Profit Margin | -34.82% | -39.54% | -111.53% | -209.26% | -58.34% | 29.21% | Upgrade
|
| Free Cash Flow Margin | -3.82% | -2.79% | -19.04% | -44.22% | -32.45% | -28.61% | Upgrade
|
| EBITDA | -1.17 | -2.17 | -7.47 | -15.48 | -18.6 | -16.86 | Upgrade
|
| EBITDA Margin | -6.10% | -11.12% | -30.92% | -43.72% | -41.81% | -40.26% | Upgrade
|
| D&A For EBITDA | 1.16 | 1.15 | 1.8 | 1.83 | 1.02 | 0.72 | Upgrade
|
| EBIT | -2.34 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade
|
| EBIT Margin | -12.15% | -17.02% | -38.37% | -48.90% | -44.10% | -41.98% | Upgrade
|
| Revenue as Reported | 19.22 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.